Microglia activation mediated by toll-like receptor-4 impairs brain white matter tracts in rats
Xinglong Yang, Jingdong Zhang, Lian Duan, Huangui Xiong, Yanping Jiang, Houcheng Liang
Microglia activation mediated by toll-like receptor-4 impairs brain white matter tracts in rats
Microglia activation and white matter injury coexist after repeated episodes of mild brain trauma and ischemic stroke. Axon degeneration and demyelination can activate microglia; however, it is unclear whether early microglia activation can impair the function of white matter tracts and lead to injury. Rat corpus callosum (CC) slices were treated with lipopolysaccharide (LPS) or LPS + Rhodobacter sphaeroides (RS)-LPS that is a toll-like receptor 4 (TLR-4) antagonist. Functional changes reflected by the change of axon compound action potentials (CAPs) and the accumulation of β-amyloid precursor protein (β-APP) in CC nerve fibers. Microglia activation was monitored by ionized calcium binding adaptor-1 immunofluorescent stain, based on well-established morphological criteria and paralleled proportional area measurement. Input-output (I/O) curves of CAPs in response to increased stimuli were significantly downshifted in a dose-dependent manner in LPS (0.2, 0.5 and 1.0 µg/mL)-treated slices, implying that axons neurophysiological function was undermined. LPS caused significant β-APP accumulation in CC tissues, reflecting the deterioration of fast axon transport. LPS-induced I/O curve downshift and β-APP accumulation were significantly reversed by the pre-treatment or co-incubation with RS-LPS. RS-LPS alone did not change the I/O curve. The degree of malfunction was correlated with microglia activation, as was shown by the measurements of proportional areas. Function of CC nerve fibers was evidently impaired by microglia activation and reversed by a TLP-4 antagonist, suggesting that the TLP-4 pathway lead to microglia activation.
lipopolysaccharide / Rhodobacter sphaeroides / toll-like receptor 4 / microglia activation / white matter tract malfunction
[1] |
Bao HX, Chen Z, Lu XL,
|
[2] |
Fu HQ, Yang T, Xiao W,
Pubmed
|
[3] |
Belanger HG, Vanderploeg RD, Sayer N. Screening for remote history of mild traumatic brain injury in VHA: A critical literature review[J]. J Head Trauma Rehabil, 2016, 31(3): 204–214
Pubmed
|
[4] |
Talavage TM, Nauman EA, Breedlove EL,
Pubmed
|
[5] |
Galgano MA, Cantu R, Chin LS. Chronic traumatic encephalopathy: the impact on athletes[J]. Cureus, 2016, 8(3): e532
Pubmed
|
[6] |
Winston CN, Noël A, Neustadtl A,
Pubmed
|
[7] |
Perez-Polo JR, Rea HC, Johnson KM,
Pubmed
|
[8] |
Smith C, Gentleman SM, Leclercq PD,
Pubmed
|
[9] |
Suenaga J, Hu X, Pu H,
Pubmed
|
[10] |
Psilodimitrakopoulos S, Petegnief V, de Vera N,
Pubmed
|
[11] |
Furukawa S, Sameshima H, Yang L,
Pubmed
|
[12] |
Sponheim SR, McGuire KA, Kang SS,
Pubmed
|
[13] |
Hamner MA, Ye Z, Lee RV,
Pubmed
|
[14] |
Lorenz P, Roychowdhury S, Engelmann M,
Pubmed
|
[15] |
Kim HS, Cho IH, Kim JE,
Pubmed
|
[16] |
Zhang F, Liu J, Shi JS. Anti-inflammatory activities of resveratrol in the brain: role of resveratrol in microglial activation[J]. Eur J Pharmacol, 2010, 636(1-3): 1–7
Pubmed
|
[17] |
Haber M, Abdel Baki SG, Grin'kina NM,
Pubmed
|
[18] |
Kielian T. Toll-like receptors in central nervous system glial inflammation and homeostasis[J]. J Neurosci Res, 2006, 83(5): 711–730
Pubmed
|
[19] |
Aravalli RN, Peterson PK, Lokensgard JR. Toll-like receptors in defense and damage of the central nervous system[J]. J Neuroimmune Pharmacol, 2007, 2(4): 297–312
Pubmed
|
[20] |
Crawford DK, Mangiardi M, Tiwari-Woodruff SK. Assaying the functional effects of demyelination and remyelination: revisiting field potential recordings[J]. J Neurosci Methods, 2009, 182(1): 25–33
Pubmed
|
[21] |
Reeves TM, Phillips LL, Povlishock JT. Myelinated and unmyelinated axons of the corpus callosum differ in vulnerability and functional recovery following traumatic brain injury[J]. Exp Neurol, 2005, 196(1): 126–137
Pubmed
|
[22] |
Medana IM, Esiri MM. Axonal damage: a key predictor of outcome in human CNS diseases[J]. Brain, 2003, 126(Pt 3): 515–530
Pubmed
|
[23] |
Streit WJ, Walter SA, Pennell NA. Reactive microgliosis[J]. Prog Neurobiol, 1999, 57(6): 563–581
Pubmed
|
[24] |
Kettenmann H. Triggering the brain's pathology sensor[J]. Nat Neurosci, 2006, 9(12): 1463–1464
Pubmed
|
[25] |
Kloss CU, Bohatschek M, Kreutzberg GW,
Pubmed
|
[26] |
Donnelly DJ, Gensel JC, Ankeny DP,
Pubmed
|
[27] |
Aida Y, Kusumoto K, Nakatomi K,
Pubmed
|
[28] |
Kutuzova GD, Albrecht RM, Erickson CM,
Pubmed
|
[29] |
Zhang J, Liu J, Fox HS,
Pubmed
|
[30] |
Nimmerjahn A, Kirchhoff F, Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo[J]. Science, 2005, 308(5726): 1314–1318
Pubmed
|
[31] |
Ransohoff RM, Perry VH. Microglial physiology: unique stimuli, specialized responses[J]. Annu Rev Immunol, 2009, 27: 119–145
Pubmed
|
[32] |
Block ML, Zecca L, Hong JS. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms[J]. Nat Rev Neurosci, 2007, 8(1): 57–69
Pubmed
|
[33] |
Tanaka T, Ueno M, Yamashita T. Engulfment of axon debris by microglia requires p38 MAPK activity[J]. J Biol Chem, 2009, 284(32): 21626–21636
Pubmed
|
[34] |
Smith ME. Phagocytosis of myelin in demyelinative disease: a review[J]. Neurochem Res, 1999, 24(2): 261–268
Pubmed
|
[35] |
Buxbaum JD, Thinakaran G, Koliatsos V,
Pubmed
|
[36] |
Kaether C, Skehel P, Dotti CG. Axonal membrane proteins are transported in distinct carriers: a two-color video microscopy study in cultured hippocampal neurons[J]. Mol Biol Cell, 2000, 11(4): 1213–1224
Pubmed
|
[37] |
Li GL, Farooque M, Holtz A,
Pubmed
|
[38] |
Deng Y, Lu J, Sivakumar V,
Pubmed
|
[39] |
Perry VH, Nicoll JA, Holmes C. Microglia in neurodegenerative disease[J]. Nat Rev Neurol, 2010, 6(4): 193–201
Pubmed
|
[40] |
Neher JJ, Neniskyte U, Brown GC. Primary phagocytosis of neurons by inflamed microglia: potential roles in neurodegeneration[J]. Front Pharmacol, 2012, 3: 27
Pubmed
|
/
〈 | 〉 |